Deep peptide recognition profiling decodes TCR specificity and enables disease-associated antigen discovery
Predicting T cell receptor (TCR) specificity on the basis of sequence is challenging because TCRs of similar sequence can recognize entirely different antigens, whereas TCRs of different sequence can recognize the same antigens. Here we present a system that integrates high-throughput yeast display with fine-tuned protein language models (pLMs) to generate deep peptide recognition profiles (PRPs) for individual TCRs, each detailing binding against millions of peptides. We provide detailed PRPs for a panel of HLA-B*27:05-restricted TCRs from persons with ankylosing spondylitis and acute anterior uveitis that almost exclusively recognize peptides through CDR3β. pLMs trained on these PRPs outperform AlphaFold3 and tFold-TCR in predicting T cell activation. We discover and validate novel candidate autoantigens, demonstrate that model generalization to new TCRs correlates with functional distance (PRP divergence) rather than sequence similarity and introduce a model-intrinsic uncertainty metric to quantify prediction confidence. This system and its associated PRP datasets offer a scalable approach to mapping TCR recognition, accelerating antigen discovery and guiding TCR engineering.
Authors
- Kevin M. Jude (ORCID: https://orcid.org/0000-0002-3675-5136)
- Michael Paley (ORCID: https://orcid.org/0000-0001-8724-3176)
- Liu Daisy Liu (ORCID: https://orcid.org/0009-0005-2939-6787)
- Isabel Risch (ORCID: https://orcid.org/0000-0003-3356-0349)
- Xinyu Xiang (ORCID: https://orcid.org/0000-0002-8358-2960)
- Xinbo Yang (ORCID: https://orcid.org/0000-0002-1755-1349)
- X Chen
- Hugh Yeh
- Joy Um
- Chunyu Wang (ORCID: https://orcid.org/0000-0001-5165-7959)
- Ben Lai
- K. Christopher Garcia (ORCID: https://orcid.org/0000-0001-9273-0278)
- Aly A. Khan (ORCID: https://orcid.org/0000-0003-3933-8538)
- Jason Perera
- Nan Wang (ORCID: https://orcid.org/0000-0001-6840-5336)
Institutions
- Memorial Sloan Kettering Cancer Center (US)
- Howard Hughes Medical Institute (US)
- Washington University in St. Louis (US)
- University of Chicago (US)
- University of Chicago Medical Center (US)
- Chan Zuckerberg Biohub San Francisco (US)
- Stanford Medicine (US)
- Stanford University (US)
Publication Details
- Journal
- Nature Biotechnology
- Published
- 2026-05-13
- DOI
- https://doi.org/10.1038/s41587-026-03128-x
- Primary Topic
- vaccines and immunoinformatics approaches
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Howard Hughes Medical Institute
- Division of Intramural Research, National Institute of Allergy and Infectious Diseases
- Cancer Research UK